Daoquan Liu

472 total citations
28 papers, 246 citations indexed

About

Daoquan Liu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Urology. According to data from OpenAlex, Daoquan Liu has authored 28 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 9 papers in Urology. Recurrent topics in Daoquan Liu's work include Urinary Bladder and Prostate Research (8 papers), Ferroptosis and cancer prognosis (6 papers) and Connexins and lens biology (4 papers). Daoquan Liu is often cited by papers focused on Urinary Bladder and Prostate Research (8 papers), Ferroptosis and cancer prognosis (6 papers) and Connexins and lens biology (4 papers). Daoquan Liu collaborates with scholars based in China and United States. Daoquan Liu's co-authors include Xinhua Zhang, Michael E. DiSanto, Jianmin Liu, Xinghuan Wang, Weixiang He, Guang Zeng, Xun Fu, Ping Chen, Yuming Guo and Junchao Zhang and has published in prestigious journals such as International Journal of Molecular Sciences, The American Journal of Cardiology and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Daoquan Liu

28 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daoquan Liu China 10 105 80 69 53 36 28 246
Xun Fu China 11 99 0.9× 76 0.9× 60 0.9× 42 0.8× 31 0.9× 18 239
Libing Hu China 9 230 2.2× 73 0.9× 42 0.6× 133 2.5× 23 0.6× 12 366
Victor C. Lin Taiwan 12 117 1.1× 113 1.4× 21 0.3× 76 1.4× 15 0.4× 40 292
Mi Kyeong Kim South Korea 10 118 1.1× 34 0.4× 26 0.4× 51 1.0× 12 0.3× 39 379
Xianyanling Yi China 9 100 1.0× 69 0.9× 23 0.3× 33 0.6× 10 0.3× 34 229
Jiajia Ma China 7 68 0.6× 21 0.3× 48 0.7× 37 0.7× 9 0.3× 23 218
Jongkeun Park South Korea 9 196 1.9× 34 0.4× 18 0.3× 97 1.8× 13 0.4× 25 361
Anna Ciotkowska Germany 13 124 1.2× 125 1.6× 237 3.4× 18 0.3× 130 3.6× 27 386
Qinggang Liu China 10 146 1.4× 43 0.5× 53 0.8× 37 0.7× 3 0.1× 23 280
Lijun Yang China 10 109 1.0× 55 0.7× 12 0.2× 44 0.8× 19 0.5× 25 350

Countries citing papers authored by Daoquan Liu

Since Specialization
Citations

This map shows the geographic impact of Daoquan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daoquan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daoquan Liu more than expected).

Fields of papers citing papers by Daoquan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daoquan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daoquan Liu. The network helps show where Daoquan Liu may publish in the future.

Co-authorship network of co-authors of Daoquan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Daoquan Liu. A scholar is included among the top collaborators of Daoquan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daoquan Liu. Daoquan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Huan, Daoquan Liu, Yan Li, et al.. (2025). Heat Shock Protein Family A Member 1A Attenuates Apoptosis and Oxidative Stress via ERK/JNK Pathway in Hyperplastic Prostate. MedComm. 6(3). e70129–e70129. 3 indexed citations
2.
Yang, Liang, Yan Li, Jianmin Liu, et al.. (2024). S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate. The International Journal of Biochemistry & Cell Biology. 169. 106551–106551. 5 indexed citations
3.
Zheng, Dong, Daoquan Liu, Xianguo Wang, et al.. (2024). Advantages of robot-assisted resection of large mediastinal tumors: a single-center preliminary study. Journal of Robotic Surgery. 18(1). 190–190. 1 indexed citations
4.
Li, Yan, Daoquan Liu, Zhen Wang, et al.. (2023). Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK /ERK1/2 pathway and resisted autophagy-related ferroptosis via AMPK/mTOR pathway in hyperplastic prostate. Journal of Translational Medicine. 21(1). 575–575. 24 indexed citations
5.
Li, Yan, Zhen Wang, Daoquan Liu, et al.. (2023). Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles. Molecular Medicine. 29(1). 139–139. 9 indexed citations
6.
Liu, Huan, Junchao Zhang, Zhen Wang, et al.. (2023). Fibronectin-1: A Predictive Immunotherapy Response Biomarker for Muscle‑Invasive Bladder Cancer. Archivos Españoles de Urología. 76(1). 70–70. 9 indexed citations
7.
Li, Yan, et al.. (2023). Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway. International Journal of Molecular Sciences. 24(5). 4911–4911. 7 indexed citations
8.
Fu, Xun, Jianmin Liu, Daoquan Liu, et al.. (2022). Glucose-regulated protein 78 modulates cell growth, epithelial–mesenchymal transition, and oxidative stress in the hyperplastic prostate. Cell Death and Disease. 13(1). 78–78. 14 indexed citations
9.
Li, Yan, et al.. (2022). The Prostate‐Associated Gene 4 (PAGE4) Could Play a Role in the Development of Benign Prostatic Hyperplasia under Oxidative Stress. Oxidative Medicine and Cellular Longevity. 2022(1). 7041739–7041739. 5 indexed citations
10.
Li, Yan, Zhen Wang, Daoquan Liu, et al.. (2022). DHCR7 promotes tumorigenesis via activating PI3K/AKT/mTOR signalling pathway in bladder cancer. Cellular Signalling. 102. 110553–110553. 16 indexed citations
12.
He, Weixiang, Xiao Wang, Qian Wang, et al.. (2021). Changes in the expression and functional activities of Myosin II isoforms in human hyperplastic prostate. Clinical Science. 135(1). 167–183. 6 indexed citations
14.
Liu, Jianmin, Daoquan Liu, Yan Li, et al.. (2021). NELL2 modulates cell proliferation and apoptosis via ERK pathway in the development of benign prostatic hyperplasia. Clinical Science. 135(13). 1591–1608. 30 indexed citations
15.
16.
Wang, Xiao, Weibing Zhang, Huiyong Liu, et al.. (2021). The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma. Frontiers in Oncology. 11. 630706–630706. 10 indexed citations
17.
Liu, Jianmin, Jing Yin, Ping Chen, et al.. (2021). Smoothened inhibition leads to decreased cell proliferation and suppressed tissue fibrosis in the development of benign prostatic hyperplasia. Cell Death Discovery. 7(1). 115–115. 15 indexed citations
18.
He, Weixiang, Xiang Han, Daoquan Liu, et al.. (2020). Changes in the expression and function of the PDE5 pathway in the obstructed urinary bladder. Journal of Cellular and Molecular Medicine. 24(22). 13181–13195. 6 indexed citations
19.
He, Weixiang, Jianmin Liu, Daoquan Liu, et al.. (2020). Alterations in the phosphodiesterase type 5 pathway and oxidative stress correlate with erectile function in spontaneously hypertensive rats. Journal of Cellular and Molecular Medicine. 24(24). 14280–14292. 3 indexed citations
20.
Liu, Daoquan, et al.. (1999). [Minimally invasive treatment in early glottic cancer and vocal cord dysplasia].. PubMed. 34(6). 337–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026